Innovating Works

P1VITAL

Desconocido
PRISM 2: Psychiatric Ratings using Intermediate Stratified Markers 2 P1VITAL LIMITED participó en un H2020: H2020-JTI-IMI2-2020-22-single-stage The current nosology of neuropsychiatric disorders provides a pragmatic approach to diagnosis and treatment choice but lacks reference to qu...
2021-05-19 - 2024-11-30 | Financiado
PRISM: Psychiatric Ratings using Intermediate Stratified Markers Sofia ref. 115916 P1VITAL LIMITED participó en un H2020: H2020-JTI-IMI2-2015-03-two-stage The current nosology of neuropsychiatric disorders allows for a pragmatic approach to treatment choice, regulation and clinical research. Ho...
2015-12-18 - 2019-09-30 | Financiado
PReDicT: Predicting Response to Depression Treatment P1VITAL LIMITED tramitó un H2020: H2020-SMEInst-2014-2015 The objective of the Predicting Response to Depression Treatment (PReDicT) project is to conduct clinical, health economic and commercial re...
2015-12-10 - 2019-11-30 | Financiado
PReDicT: Predicting Response to Depression Treatment P1VITAL LIMITED tramitó un H2020: H2020-SMEInst-2014-2015 Depression is a leading cause of disability and produces a greater decrement in health than other common chronic diseases such as angina, ar...
2015-02-05 - 2015-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.